Your digital platform to engage patients, support clinicians and scale genomics
Genetics Adviser is a digital health platform offering a customizable, evidence-based solution that improves patient engagement, streamlines workflows, and helps scale the delivery of precision genomic medicine.
A flexible suite of tools built to function independently or as an end-to-end system, ready to integrate effortlessly into your workflow.
Improve outcomes through patient engagement.
Offer patients a dynamic, engaging learning experience as they navigate pre-test education and psychosocial support.
- 95%of patients were comfortable using the platform, with patients feeling informed, empowered and engaged during consults.
Streamline your workflow.
From patient management and digital consent to delivery of results and guidance.
- 60%reduction in genetics consult time — allowing specialists to work at the top of their scope.
Backed by Science
Genetics Adviser is the only Precision Medicine digital solution validated over 10+ years and backed by ongoing research.
- Validated by randomized clinical trials.
- Consistently delivering positive patient outcomes.
- Demonstrated workflow efficiencies.
- 60%Reduction in genetics consult time — allowing specialists to work at the top of their scope.
- 96%Patients consented to testing through the Genetics Adviser.
- 95%Patients satisfied with the Genetics Adviser platform.
Why use Genetics Adviser?
Our platform is a digital patient engagement tool for pre-test education, consent and post-test support. Engaged patients make informed decisions, move through testing faster, and feel empowered—leading to better adherence and improved outcomes.
Providers
Spend less time on admin. More time delivering effective, personalized care at the top of your scope.
Labs
Drive patient engagement and adherence while accelerating lab workflows and scaling testing programs.
Researchers
Scale studies with fewer resources—streamline consenting, integrate research databases, and reach more participants.
Pharma
Identify eligible patients at scale, expand access to precision medicine, and streamline compliant therapeutic delivery.